About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Pancreatic Cancer Clinical Trials in Pennsylvania | 414 Studies

Clinical Trials Pancreatic CancerPennsylvania

Pancreatic Cancer Clinical Trials in Pennsylvania

Find 414 clinical trials for pancreatic cancer near Pennsylvania. Connect with research centers in your area.

All Pancreatic Cancer trials nationwide All trials in Pennsylvania

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 261-280 of 414 trials

CompletedA Study of MGC018 in Combination With MGD019 in Participants With Advanced Solid TumorsStudy CP-MGC018-02 is a study of vobramitamab duocarmazine (MGC018) in combination with lorigerlimab (MGD019).NCT05293496·Los Angeles, California and 9 others CompletedTriacetyluridine and Fluorouracil Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced, or Metastatic Pancreatic CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00024427·Birmingham, Alabama and 28 others

Pancreatic Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

Active not recruitingNivolumab and Ipilimumab in Treating Patients With Rare TumorsThis phase II trial studies nivolumab and ipilimumab in treating patients with rare tumors.NCT02834013·Birmingham, Alabama and 1006 others

TerminatedCAR T Cell Immunotherapy for Pancreatic CancerPhase I study to establish the safety and feasibility of both intravenous administration and local delivery of lentiviral transduced huCART-meso cells in patients with…NCT03323944·Philadelphia, Pennsylvania

Active not recruitingSafety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLCThis is a First-in-Human Phase IA/IB/II open label dose escalation study of intravenous (IV) administration of ONC-392, a humanized anti-CTLA4 IgG1 monoclonal antibody, as single…NCT04140526·Springdale, Arkansas and 36 others

UnknownStudy of Effect of Azeliragon in Patients Refractory to Prior Treatment of Metastatic Pancreatic CancerThis is an open label study to determine the safety and preliminary evidence of a therapeutic effect of azeliragon in patients refractory to prior treatment of metastatic…NCT05766748·Los Angeles, California and 5 others

CompletedResilience and Exercise in Advanced Cancer TreatmentThis is a pilot study to evaluate the feasibility of, adherence to, and early efficacy of Band Together, a strength-training and walking program (intervention arm) vs. education…NCT02680990·Hershey, Pennsylvania

TerminatedParicalcitol Plus Gemcitabine and Nab-paclitaxel in Metastatic Pancreatic CancerThis research study is a two stage study which consists of a safety run-in phase and a randomized phase 2 study which include subjects with previously-untreated, metastatic…NCT03520790·Boston, Massachusetts and 1 other

CompletedTTX-030 in Combination With Immunotherapy and/or Chemotherapy in Subjects With Advanced CancersThis is a phase 1/1b study of TTX-030 in combination therapy, an antibody that inhibits CD39 enzymatic activity, leading to accumulation of pro-inflammatory adenosine triphosphate…NCT04306900·Scottsdale, Arizona and 31 others

RecruitingPancreatic Cancer Early Detection ConsortiumThe purpose of the Pancreatic Cancer Early Detection (PRECEDE) Consortium is to conduct research on multiple aspects of early detection and prevention of pancreatic ductal…NCT04970056·Phoenix, Arizona and 59 others

WithdrawnA Study of Fractionated 90Y-hPAM4 Plus Gemcitabine in Pancreatic Cancer Patients Receiving at Least 2 Prior Therapies.90Y-hPAM4 is administered weekly for 3 weeks combined with 4 weekly doses of gemcitabine to assess.NCT01510561·Gilbert, Arizona and 23 others

CompletedPediatric Longitudinal Cohort Study of Chronic PancreatitisThe investigators will enroll a total of 628 patients under 18 years of age with ARP or CP.NCT03672422·Beverly Hills, California and 21 others

Active not recruitingStudy of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C)The purpose of this study is to find out whether the study drug, LY3537982, is safe and effective in cancer patients who have a specific genetic mutation (KRAS G12C).NCT04956640·Birmingham, Alabama and 48 others

Active not recruitingWASH Trial: Intraoperative Lavage as a Treatment for Pancreatic CancerThe goal of this clinical trial is to learn if a special washing treatment used during surgery can help people with pancreatic cancer live longer.NCT02757859·Philadelphia, Pennsylvania

TerminatedLong Term Follow-Up Study for Subjects Previously Treated With Algenpantucel-L (HyperAcute-Pancreas) ImmunotherapyThis protocol (NLG0705) provides a mechanism for the 15-year follow-up period that the FDA requires for all participants in gene transfer protocols and assures that adequate…NCT03165188·Los Angeles, California and 14 others

CompletedTemozolomide and Pazopanib Hydrochloride in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors That Cannot Be Removed By SurgeryThis phase I/II trial studies the side effects and best dose of temozolomide and pazopanib hydrochloride when given together and to see how well they work in treating patients…NCT01465659·Chicago, Illinois and 4 others

Active not recruitingEvaluation of a Mixed Meal Test for Diagnosis and Characterization and Type 3c Diabetes Mellitus Secondary to Pancreatic Cancer and Chronic Pancreatitis (DETECT)The Coordinating and Data Management Center (CDMC) at MD Anderson Cancer will be responsible for the coordination and data management for the Evaluation of a mixed meal test for…NCT03460769·Los Angeles, California and 9 others

CompletedA Study Evaluating IPI-926 in Combination With Gemcitabine in Patients With Metastatic Pancreatic CancerStudy IPI-926-03 is a Phase 1b/2 clinical trial to evaluate IPI 926 in combination with gemcitabine in patients with previously untreated metastatic pancreatic cancer.NCT01130142·Tucson, Arizona and 27 others

RecruitingMaintenance Niraparib Plus Ipilimumab in Patients With Metastatic Pancreatic Adenocarcinoma Whose Disease Has Not Progressed on Platinum-Based ChemotherapyThe main goal of this study is to look at the effectiveness and anti-tumor activity (preventing growth of the tumor) of the drugs niraparib and ipilimumab, on the patients and…NCT06747845·Boston, Massachusetts and 1 other

TerminatedA Randomized Trial of Two Surgical Techniques for Pancreaticojejunostomy in Patients Undergoing PancreaticoduodenectomyThe purpose of this trial is to determine whether a mucosa-to-mucosa technique of pancreaticojejunostomy will improve the pancreatic fistula rate.NCT00359320·Philadelphia, Pennsylvania

PreviousPage 14 of 21Next

Other Conditions in Pennsylvania

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia